Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Fantastic...call...lol...
Very quiet...and still an MC under 100M.
$2 wall is up... board is quit for the run we are seeing.
I am all out here...Hope it contiues for all that arfe holding...
I see it. Someone's taking it out!
1.50 wall get bought!
No complaints here!
Looks like we are going to end up in NK. I'll take that!
Yo're right! I also planned to jump in for 2-4 months in April 2017. Than I bought more, later more to average down. Total failure until now. I hope Kman will trick somebody else letting us to sell off with some profit or die! Arimoclomol isn't a lie!
GLTY
Me too me too!! I took a bet with this company, that they would have successful P3 results. But as you know they screwed us for not letting investors know certain data would be exempt, making the trial appear that it failed. Then a few months later, When that exempted data was Unblinded or whatever, all of a sudden the trial was a success. But as we know, Wall street wasn’t buying it, and the price never recovered. Still makes me sick to my stomach to this day that cytrx did this to us!
Not at the moment...
Interesting volume. Hope that wasn't it...
It's possible, bc NK'is down Today
Hi Knox,
Are You still in? Seeing Today movement I hope to see the end of our tunnel! $1.5 wasn't bad suddenly!
GLTY
NK buyout? That would be ideal!!!
I hope you have to scan Cytr for 3 more month because of rising volume by higher and higher price! I'm suffering here for almost 4 years now expecting the big jump to break $10!
GLTY
I don't know a damn thing about this company. :(
I just look for ATR's that hit d(ATR)/dt = 0, then have d(ATR)/dt > 0 on rising volume, and CYTR hit my scan last month. GL!
Finally CYTR arrived to broke $1, but we're very far from R/S price $2,4 or from expectations of Aldoxorubicin phase3 in Summer of 2017, when Soon-Shiong jumped in at $6.6! Maybe next year something bigger could happen with Aldox and Aromoclomol.
Volume's been picking up the past few trading days, and today it looks like someone couldn't wait any longer. Fingers crossed. :)
Back in at 1.02 we will see if paying up for this is a mistake!
Looks like it's about to bust a move up.
Been waiting for the past month.
There's a 1.78M share buy order currently sitting on the CYTR .99 bid.
Sad, another one time Nasdaq star, CYTR relegated to OTC
Just In: $CYTR CytRx Highlights Use of Licensed Drug Aldoxorubicin in ImmunityBio's Expanded Phase 2 Study of Pancreatic Cancer Treatment
Third-Line Cohort Added to Phase 2 Pancreatic Cancer Trial for Combination Immunotherapy That Includes Aldoxorubicin, ImmunityBio’s N-803 and NantKwest’s PD-L1 t-haNK Three Trial Sites in California and South Dakota Will Initially Enroll 298 Patients Across...
Find out more CYTR - CytRx Highlights Use of Licensed Drug Aldoxorubicin in ImmunityBio's Expanded Phase 2 Study of Pancreatic Cancer Treatment
Jerald A. Hammann please sell your shares.
Whats the next catalyst?
Thanks... I couldn't find anything.
I don't think there is any. ImmunityBio has trials, but no info about Aldox role. I'm afraid no chance that it'd help us!
Trying to determine if there is any CYTR involvement in NK COVID 19 R&D?
Hi Step, Yes this board is dead since Knox and me cut our discussion. You're right that we believed pship agreement that's why we didn't sell out in August 2017 when PPS was close to $1 ($6 after R/S). I'm afraid it was a clever trick of Soon to attache all MS payment some Aldox result. (i.e. filing the NDA) or manufacturing and commercialisig Aldox as a drug. He had another (secret) plan: to use Aldox in all NANT trials without paying a single $! He bought shares - at a higyher price level . that's all. It's a very easy and cheap way to get Aldox rights. I don't know SK was involved, but I think yes!
I hope once PSS will be that position when Aldox NDA could open some possibilty to step ahead, and he'll do it. Then CYTR could earn some MS and pps will jump up! Maybe when Abraxane right Will expire or some trials need to support by a real phase3 drug!
I didn't think that investing here could last so long!
Waiting game!
GLTY
OK...if you believe this is a viable company...load up, it's on sale.
If we didnt have credible licensing agreements I would agree, but we do. So not a scam. A way to line SKs pockets? Yes. But a scam? No
It's a scam....
Ive been in Scams, this isnt a scam soley based on the fact it has licenstagrsementa with two proven drugs that are in the hands of better people of who will owe Cytrx many a moneys when those drugs hit the market
Since this company has been a scam for years the board dying is long overdue.
The pr's are regurgitated trash from prior releases.
People still buying into the zombies scam of fake pr’s
This should be a TRULY MEANINGFUL GOLDEN CROSS rising like a 'PHEONIX' from a nice level plateau. Considering it's coming from September 16, 2015 crossover means a lot of tenacity from the management to believe in their research and now trust from their investors.
I was surprised in the Institutional liquidation and no new positions taken the last quarter! I would have expected more volume today and interest with the crossover considering what they have in the pipeline.
FWIW
Twodogs
CYTR...70...Hit 75 Hod on the 50/200 cross...
Time to roll?
Followers
|
206
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
7747
|
Created
|
01/22/05
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |